[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fVP39fSa_mjo2r1gQNjAI06ZYICOD4l1XLaR_rnyXz9s":8,"$fYMus0igdq3RW1hSSrrUaLe9Gx8vggxzdYb4vMm7K9_g":56,"$fdtAZuufnei4-SW6goR2HZFxU-riNPchv3lonfw62mBQ":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},75319,867295,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//dhBa30GXqc9E39XVnlE5Gi3DTsMG7Arv.png","秦继龙","聊城市第二人民医院","甲状腺乳腺外科","住院医师",119,0,"乳腺癌肺转移药品使用指南：关键细节与安全诀窍","","https://ystcdn.venuertc.com/venue/AI/85ab99db-0557-42ca-892e-b6a1dee1219d.jpg","\u003Cdiv class=\"material_container\">\n  \u003Ch1 id=\"material_title\" class=\"material_title\">乳腺癌肺转移药品使用指南：关键细节与安全诀窍\u003C/h1>\n  \u003Cdiv class=\"material_intro\">\n    \u003Cp>\u003Cspan style=\"font-size:20px;\">💊\u003C/span>说起来，乳腺癌肺转移的治疗用药涉及多种类型，比如内分泌药物、靶向药和骨改良药物。不管是来曲唑片、CDK4/6抑制剂（如达尔西利）还是地舒单抗，使用时都各有门道。本文将带你梳理\u003Cstrong>7个关键用药细节\u003C/strong>，帮你理清每种药品的安全用法、服药技巧与注意事项，减少用药风险，让治疗更安心。\n    \u003C/p>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f0f4f8 60%, #e0e7ef 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">📝\u003C/span>1. 药品成分与剂型特点\u003C/h2>\n    \u003Cul class=\"material_list\">\n      \u003Cli>\u003Cstrong>来曲唑（Letrozole）\u003C/strong>：非甾体类芳香化酶抑制剂，常见剂型为2.5mg片剂，口服。\u003C/li>\n      \u003Cli>\u003Cstrong>达尔西利（Dalpiciclib）\u003C/strong>：CDK4/6抑制剂，多以片剂形式使用（规格为100mg和150mg），按疗程口服。\u003C/li>\n      \u003Cli>\u003Cstrong>地舒单抗（Denosumab）\u003C/strong>：骨改良药，皮下注射剂型，每支通常含120mg。\u003C/li>\n    \u003C/ul>\n    \u003Cp>不同药物有不同的给药途径：来曲唑和达尔西利属口服药物，地舒单抗为皮下注射药品。选用时应根据医生方案，不可自行更换或混用剂型。\u003C/p>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f7f9fc 70%, #e6ebf3 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">🔬\u003C/span>2. 药理作用机制简介\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑\u003C/strong>：通过抑制体内芳香化酶，阻断雌激素合成；用于减少雌激素影响。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利\u003C/strong>：干扰细胞周期相关蛋白（CDK4/6），阻断细胞分裂，使细胞增殖减缓。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗\u003C/strong>：针对RANKL蛋白，抑制破骨细胞活性，减少骨吸收。\u003C/li>\n      \u003C/ul>\n      \u003Cp>这些机制决定了药品在治疗方案中的核心位置，选择药物需要结合个人情况以及治疗目标。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f5eefd 60%, #e0e6fc 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">⏰\u003C/span>3. 正确用法用量与服药时间\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑：\u003C/strong>常规为每日1次，每次2.5mg，餐前餐后均可，建议每天同一时间服用。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利：\u003C/strong>按医生处方，每天1次或间歇方案，剂量视个人不同（通常为100mg~150mg）；整片吞服，勿嚼碎。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗：\u003C/strong>每4周皮下注射1次，每次120mg，注射部位需轮换。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：用药前务必详细核对剂量，不可随意增减。口服药应以清水送服，避免与果汁、牛奶混用以免影响药物吸收。\u003C/p>\n      \u003Cp>有位患者曾因漏服达尔西利而影响疗效，后改为定时提醒，从而保持了用药规律。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #eef8f3 80%, #dff1e8 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">👩‍🦳\u003C/span>4. 特殊人群用药调整\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong>对来曲唑和达尔西利耐受性可能下降，用量需按医生指示酌情减量。\u003C/li>\n        \u003Cli>\u003Cstrong>肝、肾功能不全者：\u003C/strong>地舒单抗不依赖肾脏清除，但来曲唑和达尔西利需特别关注肝功能，必要时调整剂量。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇、哺乳期妇女：\u003C/strong>上述三类药物均\u003Cstrong>禁用\u003C/strong>，即使有治疗需求，也必须由专业医生全程监护。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童：\u003C/strong>这些药品暂未推荐用于儿童。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：用药前向医生充分说明自身情况，定期检测肝功能和肾功能，避免并发风险。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #fff4e5 80%, #ffeec4 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">🔄\u003C/span>5. 药物相互作用要点\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑：\u003C/strong>与噻嗪类利尿剂、雌激素制剂同用会降低疗效；禁与雌激素药物合用。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利：\u003C/strong>强效CYP3A4抑制剂如酮康唑、红霉素会使血药浓度增高，易致不良反应；服用期间避免葡萄柚汁。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗：\u003C/strong>未发现常用药物有严重相互作用，但与钙片、维生素D可联合使用做骨保护。\u003C/li>\n      \u003C/ul>\n      \u003Cp>需要注意：用药前请向医生或药师报备正在服用的全部药品，包括非处方药和保健品。有患者在联合抗菌药时出现了达尔西利血药浓度异常，更换药品后问题得以解决。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #eaf9ff 80%, #d1ecfa 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">⚠️\u003C/span>6. 常见不良反应及处理方法\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑：\u003C/strong>常见：关节痛、热潮红、头晕。严重：骨密度下降。出现关节不适可使用镇痛药缓解，持续不适需及时报告医师。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利：\u003C/strong>常见：白细胞减少、乏力。严重：严重感染风险。监测血常规，一旦出现发热或持续疲劳，立即就医。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗：\u003C/strong>常见：低钙血症、肌肉抽搐。严重：顎骨坏死（罕见）。注射前后应补充钙和维生素D。出现口腔溃疡或顎部肿胀要及时就诊。\u003C/li>\n      \u003C/ul>\n      \u003Cp>临床数据显示，达尔西利导致中性粒细胞减少的发生率约为50%\u003Csup>[1]\u003C/sup>，但规范监测可有效降低严重并发风险。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f2f6ee 80%, #deecd5 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">📦\u003C/span>7. 药品储存与有效期管理\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑：\u003C/strong>需密封保存于干燥阴凉处，气温应保持在25℃以下，避免阳光直射。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利：\u003C/strong>原包装保存，远离高温潮湿环境。拆封后如未用完，需在医嘱下处理。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗：\u003C/strong>避光冷藏，温度2～8℃，切勿冷冻，开封后即用。\u003C/li>\n      \u003C/ul>\n      \u003Cp>过期或变质药品应交由药师处理，不建议自行丢弃。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #faf5fc 80%, #e9dfed 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">⏳\u003C/span>8. 用药漏服与过量应对\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>来曲唑：\u003C/strong>漏服后尽快补服，距离下次服药不足12小时，可跳过；不要一次多服。过量服用可能引发头晕、恶心，应立即报告医生。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利：\u003C/strong>漏服同样只需尽快补服1次，无需增加剂量。过量服药有感染等风险，应尽快就医。\u003C/li>\n        \u003Cli>\u003Cstrong>地舒单抗：\u003C/strong>错过1次可等待下次周期补打，不可随意提前注射。若误用多次需专业处理。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：用药期间设定提醒，尤其对口服长期药品，漏服和乱服都容易影响疗效。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #eaf4fa 90%, #dbe4ee 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">📖\u003C/span>9. 简明用药案例分享\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>一位女性患者术后联合来曲唑与达尔西利，药物相互作用未管理，调整后用药安全性提升。\u003C/li>\n        \u003Cli>临床有患者误将地舒单抗冷冻存放，药品失效，后经药师指导规范储存方式，大幅降低药物浪费。\u003C/li>\n        \u003Cli>老年患者服用来曲唑出现骨密度下降，及时补充钙剂与维生素D后得到缓解。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f8fbef 80%, #e2eddc 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">🛡️\u003C/span>10. 数据与安全性警示\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>临床研究显示，地舒单抗导致低钙血症比例约为5%-10%\u003Csup>[2]\u003C/sup>。\u003C/li>\n        \u003Cli>来曲唑使用期间骨密度丢失风险增加，双能X线检测提示应定期随访。\u003C/li>\n        \u003Cli>达尔西利常见的不良反应以血象降低为主，但规范管理后发生率明显下降。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：定期监测血常规和矿物质水平，出现异常及时和医师沟通，保证服药安全。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #f7fbfa 80%, #e3eded 100%); padding:32px; border-radius:12px; margin-bottom:32px;\">\n    \u003Ch2 class=\"material_subtitle\">\u003Cspan style=\"font-size:20px;\">📝\u003C/span>11. 总结与用药建议\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul>\n        \u003Cli>来曲唑、达尔西利、地舒单抗在乳腺癌肺转移治疗中各有位置，用药时一定要明晰剂型和时间。\u003C/li>\n        \u003Cli>关注特殊人群调整、安全储存和不良反应识别，是保证疗效和安全的关键。\u003C/li>\n        \u003Cli>用药期间应主动记录药品名称、剂量和服药情况，遇疑问随时咨询药师。\u003C/li>\n        \u003Cli>合理用药能够最大限度发挥药物疗效，并将副作用和风险降到最低。\u003C/li>\n      \u003C/ul>\n      \u003Cp>实际上，耐心、细致的用药管理是治疗成功的重要保障。记住，把药用对，比治什么更重要！\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \n  \u003Cdiv class=\"material_section\" style=\"background: linear-gradient(to right, #eef0f4 80%, #cfd4de 100%); padding:24px; border-radius:10px; margin-bottom:32px;\">\n    \u003Ch3 class=\"material_ref_title\">\u003Cspan style=\"font-size:18px;\">🔗\u003C/span>参考文献\u003C/h3>\n    \u003Col class=\"material_ref_list\" style=\"font-size:16px;\">\n      \u003Cli>\n        Hortobagyi GN, Stemmer SM, Burris HA, et al. (2016). Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 375(18):1738-1748. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27797153/\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Bone HG, Chapurlat R, Brandi ML, et al. (2011). The Effect of Denosumab on Bone Density and Turnover in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors: 12-Month, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study. \u003Ci>Journal of Clinical Oncology\u003C/i>, 29(22):2878-2885. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21709197/\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Goss PE, Ingle JN, Martino S, et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 349(19):1793-1802. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/14551341/\">PubMed\u003C/a>\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material_container {\n  font-family: 'Segoe UI', Arial, sans-serif;\n  max-width: 890px;\n  margin: 32px auto;\n  background: #fcfcfc;\n  border-radius: 14px;\n  box-shadow: 0 3px 18px rgba(63,94,251,.09);\n  padding: 28px 36px 48px 36px;\n}\n.material_title {\n  font-size: 39px;\n  font-weight: 800;\n  text-align: center;\n  background-image: linear-gradient(to right, #d1ecfa, #eec7fa 85%);\n  color: #2a3357;\n  padding: 34px 0 22px 0;\n  border-radius: 22px 22px 0 0 ;\n  letter-spacing: 1.1px;\n  box-shadow: 0 2px 14px rgba(174,185,224,0.07);\n}\n.material_intro {\n  font-size: 22px;\n  color: #324164;\n  background: linear-gradient(to right, #f4f8fc 80%, #ede8fa 100%);\n  margin-bottom: 32px;\n  padding: 21px 25px;\n  border-radius: 16px;\n  box-shadow: 0 2px 10px rgba(53,77,114,.08);\n}\n.material_section {\n  margin-bottom: 32px;\n}\n.material_subtitle {\n  font-size: 28px;\n  font-weight: 700;\n  color: #345;\n  margin-bottom: 14px;\n  text-shadow: 0px 1px 7px rgba(151,166,161,0.10);\n  padding-left: 3px;\n}\n.material_content {\n  font-size: 19px;\n  color: #2d3b54;\n  line-height: 1.75;\n  padding-left: 6px;\n}\n.material_list,\n.material_ref_list {\n  margin-top: 0;\n  margin-bottom: 16px;\n  padding-left: 26px;\n}\n.material_list li,\n.material_ref_list li {\n  font-size: 19px;\n  margin-bottom: 12px;\n  line-height: 1.7;\n}\n.material_ref_title {\n  font-size: 23px;\n  font-weight: 600;\n  color: #37506e;\n  margin-bottom: 12px;\n}\n.material_ref_list {\n  color: #2d3750;\n}\n.material_content ul {\n  padding-left: 13px;\n}\n.material_content li {\n  margin-bottom: 8px;\n}\n@media (max-width: 990px) {\n  .material_container {\n    padding: 16px 8px 32px 8px;\n    max-width: 99%;\n  }\n  .material_title {\n    font-size: 26px;\n    padding: 19px 0 11px 0;\n  }\n  .material_intro {\n    font-size: 18px;\n    padding: 11px 7px;\n  }\n  .material_subtitle {\n    font-size: 21px;\n    margin-bottom: 9px;\n  }\n  .material_content, .material_list li, .material_ref_list li {\n    font-size: 15px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"material_container\">\n  \u003Ch1 id=\"material_title\" class=\"material_title\">乳腺癌肺转移药品使用指南：关键细节与",569,"2025-12-05 00:19:32","乳腺癌临床分期2常用药品用药实用指南","乳腺癌, 药物使用指南, 高风险药物, 用药安全, 剂型与服用技巧, 特殊人群用药","了解乳腺癌临床分期2的常用药品使用指南，掌握服用时间、剂型、药物相互作用等重要信息，确保用药安全有效。","2025-12-15 17:31:22",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]